CSIMarket


Edwards Lifesciences Corporation  (EW)
Other Ticker:  
 

Edwards Lifesciences Corporation

EW's Fundamental analysis








Looking into Edwards Lifesciences growth rates, revenue grew by 13.75 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 681

Medical Equipment & Supplies industry recorded growth of revenues by 6.74 %

Edwards Lifesciences's net profit deacreased by -7.2 % in IV. Quarter 2023 year on year, to $370 millions.

More on EW's Growth


Edwards Lifesciences
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Company is currently trading with Price to Cash flow multiple of 151.74 in trailing twelve-month period.
Company
40.6
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.49.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.46.


More on EW's Valuation
 
 Total Debt (Millions $) 597
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 382,420
 Net Income/Employee (TTM) $ 89,134
 Receivable Turnover (TTM) 8.04
 Tangible Book Value (Per Share $) 8.26

Edwards Lifesciences
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Company is currently trading with Price to Cash flow multiple of 151.74 in trailing twelve-month period.
Company
40.6
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.49.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.46.

Edwards Lifesciences Price to Book Ratio is at 8.48 higher than Indusry Avg. of -548.02, and higher than S&P 500 Avg. of 0.01

More on EW's Valuation

  Market Capitalization (Millions $) 56,962
  Shares Outstanding (Millions) 610
  Employees 15,700
  Revenues (TTM) (Millions $) 6,004
  Net Income (TTM) (Millions $) 1,399
  Cash Flow (TTM) (Millions $) 375
  Capital Exp. (TTM) (Millions $) -266
  Total Debt (Millions $) 597
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 382,420
  Net Income/Employee(TTM) $ 89,134
  Receivable Turnover Ratio (TTM) 8.04
  Tangible Book Value (Per Share $) 8.26

  Market Capitalization (Millions $) 56,962
  Shares Outstanding (Millions) 610
  Employees 15,700
  Revenues (TTM) (Millions $) 6,004
  Net Income (TTM) (Millions $) 1,399
  Cash Flow (TTM) (Millions $) 375
  Capital Exp. (TTM) (Millions $) -266


    EW's Profitability Comparisons
Edwards Lifesciences faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 26.09 % from 28.26 % in III. Quarter.

Edwards Lifesciences net profit margin of 24.11 % is currently ranking no. 11 in Medical Equipment & Supplies industry, ranking no. 41 in Healthcare sector and number 463 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 3.38
  Total Debt to Equity (MRQ) 0.09
  Tangible Leverage Ratio (MRQ) 0.54
  Asset Turnover Ratio (TTM) 0.72
  Inventory Turnover Ratio (TTM) 1.35



Edwards Lifesciences faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 26.09 % from 28.26 % in III. Quarter.

Edwards Lifesciences net profit margin of 24.11 % is currently ranking no. 11 in Medical Equipment & Supplies industry, ranking no. 41 in Healthcare sector and number 463 in S&P 500.

More on EW's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com